Incyte’s Oral JAK1 Inhibitor Shows Potential In Facial, Full Body Vitiligo

 
• By Joseph Haas
Vitiligo
Incyte is hoping to bring vitiligo patients multiple therapeutic options • Source: Shutterstock

More from Clinical Trials

More from R&D